CYSTOGRAFIN DILUTE: DIATRIZOATE MEGLUMINE INJECTION.
DIATRIZOATE MEGLUMINE INJECTION. Key specifications include special_features: STOPPER SHALL BE COMPATIBLE WITH PIERCING DEVICE OF THE STOCK LISTED INTRAVENOUS INJECTION SETS, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 300.000 MILLILITERS, active_medicament_medicinal_strength: 18.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-265-0055, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | STOPPER SHALL BE COMPATIBLE WITH PIERCING DEVICE OF THE STOCK LISTED INTRAVENOUS INJECTION SETS |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 10 |
| primary_container_content_quantity | 300.000 MILLILITERS |
| active_medicament_medicinal_strength | 18.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | DIATRIZOATE MEGLUMINE INJECTION USP 300ML BOTTLE 10S PG |
| NSN | 6505-01-265-0055 |
| PRIMARY CONTAINER CONTENT QUANTITY | 300.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| SPECIAL FEATURES | STOPPER SHALL BE COMPATIBLE WITH PIERCING DEVICE OF THE STOCK LISTED INTRAVENOUS INJECTION SETS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DIATRIZOATE MEGLUMINE INJECTION USP 300ML BOTTLE 10S PG |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 18.000 PERCENTAGE, W/V DIATRIZOATE MEGLUMINE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 10 |
No substitute or cross-reference records for this part.